Shares of cannabis firm Tilray (TLRY) skyrocket on report of making a deal with Privateer Holdings

: TLRY | Tilray, Inc. - Class 2  News, Ratings, and Charts

TLRY – Tilray and Privateer strike a deal to release the cannabis-focused fund’s shares over the next two years.

Key Points

  • Tilray and Privateer strike a deal to release the cannabis-focused fund’s shares over the next two years.
  • Privateer holds 75 million Tilray shares, or 77% of the outstanding shares, worth $2.9 billion as of Friday.
  • The deal will allow Tilray to pursue investments from institutional and strategic investors.

Tilray shares surged more than 13% Monday in premarket trade after the Canadian pot company announced it struck a deal with its majority shareholder, a cannabis company backed by venture capitalist Peter Thiel, to sell the fund’s stake gradually over the next two years.

Privateer Holdings, a private equity fund concentrated in the cannabis sector, formed Tilray in 2013 and took it public last summer. Thiel’s Founders Fund was an early backer of Privateer in 2014.

Privateer holds 77% — 75 million shares — of Tilray’s outstanding shares worth roughly $2.91 billion at Friday’s closing price of $38.80. That stake was worth more than $16.05 billion at the company’s peak price of $214.06 in September.

Short sellers have bet Privateer would flood the market with Tilray shares, with 24.2% of the float currently shorted, according to FactSet. The deal sets up a schedule and conditions for Privateer’s stake to be released over the next two years, which Tilray hopes will clear the stock overhang.

Tilray will acquire Privateer in a downstream merger, releasing Privateer’s current stake to the market over the next two years in what is expected to be a tax-free deal for the fund’s investors. In the first year following the transaction, shares will be sold to institutional and strategic investors, which Tilray will determine. Remaining shares will be released over the second year at a staggered rate.

“Privateer is giving Tilray a lot of operational flexibility and obviously believes in long-term value of this business and is not pushing to sell its shares as soon as possible, so it’s kind of mutually beneficial, this transaction, for both parties,” Tilray Chief Financial Officer Mark Castaneda said in an interview.

Tilray has signed numerous partnerships, including with brewing giant Anheuser-Busch InBev, retail and consumer brands conglomerate Authentic Brands Group and pharmaceutical company Novartis. Some of its competitors have taken large investments from strategic investors. Alcohol company Constellation Brands purchased a 38% stake in Canopy Growth last year, while tobacco giant Altria bought 45% of Cronos.

“Tilray and the cannabis industry is disrupting many industries, and there is a lot of long-term interest from really all those industries — pharmaceutical, alcohol, (consumer packaged goods) and tobacco — of investing into this space on a long-term basis,” Castaneda said. He said he does not expect all 75 million shares to be sold.

 

 

 

 

 

 

 

 

 


Tilray Inc. Cl 2 shares were trading at $42.78 per share on Monday morning, up $3.98 (+10.26%). Year-to-date, Tilray, Inc. - Class 2 (TLRY - Get Rating) has declined -39.35%, versus a 16.46% rise in the benchmark S&P 500 index during the same period.

Tilray, Inc. - Class 2 (TLRY - Get Rating) currently has a StockNews.com POWR Rating of F (Strong Sell), and is ranked #113 of 207 stocks in the Medical – Pharmaceuticals category.

 

 

 

 

 

 

 

 


This article is brought to you courtesy of CNBC.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

: hexo | HEXO Corp. Common Shares News, Ratings, and Charts

Why this analyst just rated shares of HEXO a “buy”

Yesterday MKM Partners analyst Bill Kirk initiated coverage of Hexo Corp. (HEXO) with a "buy" rating.
NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

What is the Worst Case Scenario for Stocks?

We need to consider just how bad things would get for the S&P (SPY) if the China deal fell apart. Yes, other indices would likely take it even harder. Let's review how this would likely unfold and our trading strategies.
: CGC | Canopy Growth Corporation  News, Ratings, and Charts

What's next for Canopy Growth (CGC), as Bruce Linton finally moves on

For the world's largest cannabis company by market cap, Canopy Growth (CGC) has seen its fair share of shake-ups in the past few months.
NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

What Quadruple Witching Friday Means for Investors

A bigger factor in the dampening of the witching effect is the explosion of new products and expansion of expirations offered. Continue reading to see what quadruple witching Friday means for investors.
NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

Repo Market Chaos Could Lead to a Crisis

Chaos in short-term funding markets this week forced the Federal Reserve to step in with a series of overnight rescue operations. Continue reading for more details.

Read More Stories


More Tilray, Inc. - Class 2 (TLRY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All TLRY News
Page generated in 1.2209 seconds.